Company - Corporate Actions - Earnings
Innate Pharma (IPHA) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 IPHA 4.61%
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 KZIA 1.04%
Galapagos NV (GLPG) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The annoucened EPS was $0.14The estimated revenue...
September 12, 2024 GLPG 2.81%
X.T.L. Biopharmaceuticals Ltd. (XTLB) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 11, 2024 XTLB -1.67%
Can-Fite Biopharma Ltd (CANF) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.36The estimated revenue is $100000
...
September 11, 2024 CANF 1.95%
Turkcell Iletisim Hizmetleri A.S. (TKC) confirmed earnings release on September 12, 2024, After the market for the quarter ending June 30, 2024.
...
September 11, 2024 TKC 0.26%
MYT Netherlands Parent BV (MYTE) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $0.07The estimated revenue is $252140000
...
September 11, 2024 TKC 0.26%
Boqii Holding Limited (BQ) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $44260600
...
September 11, 2024 BQ -3.10%
DouYu International Holdings Ltd (DOYU) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 11, 2024 DOYU 0.23%
Innate Pharma (IPHA) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 11, 2024 IPHA 4.61%